What is a concern after administering oxytocin in a non-stress contraction test?

Administering oxytocin during a non-stress contraction test is primarily aimed at inducing uterine contractions to assess fetal well-being. One of the main concerns is the potential for fetal distress if the oxytocin does not effectively stimulate contractions. If nipple stimulation or the administration of oxytocin fails to produce adequate contractions, the fetus may not receive sufficient oxygenation, leading to signs of distress.

In this context, fetal distress can manifest as changes in the fetal heart rate pattern, indicating that the fetus may not be coping well with the contractions. Continuous monitoring of the fetal heart rate during this process is crucial to identify any potential issues early. Therefore, the concern revolves around the possibility that the desired physiological response (contractions) does not occur, resulting in an inadequate assessment of fetal health and the potential for more significant complications.

The other options, while relevant in different contexts, do not align with the immediate implications of administering oxytocin during the test. Concerns such as increased risk of infection typically arise in different clinical scenarios, and issues like obesity or lack of fetal heart rate monitoring, while important, are not direct concerns specifically tied to the administration of oxytocin in this testing situation.